Alcidion (ASX:ALC) has completed a capital raise
Alcidion (ASX:ALC) has raised funds to continue its growth strategy.
Alcidion is transforming healthcare with smart, intuitive and complementary software products and services that create a unique offering in the global healthcare market. These solutions support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient systems.
Oaklins’ team in Australia acted as lead manager in this transaction.
Talk to the deal team
Related deals
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.
Learn moreAgar Scientific has been acquired by Calibre Scientific
Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.
Learn moreFrenkel Topping has completed the placing of new shares
Frenkel Topping has raised funds to continue consolidating the highly fragmented professional services marketplace in this niche sector.
Learn more